Bacteriology of community-acquired pneumonia, antimicrobial susceptibility pattern and associated risk factors among HIV patients, Northeast Ethiopia: cross-sectional study

Objective: Pneumonia is an opportunistic infection and it is a major cause of mortality and morbidity among human immunodeficiency virus/acquired immune deficiency syndrome-positive patients. Previous studies have shown the dominant pathogens bacterial isolates were K. pneumoniae 27.0%, S. aureus 20.8%, S. pneumoniae 18.8% and E. coli 8.3%. This study aimed to determine bacteriology of community-acquired pneumonia, antimicrobial susceptibility pattern and associated risk factors among human immunodeficiency virus patients in the Northeast Ethiopia: cross-sectional study. Methods: A health facility-based cross-sectional study was conducted from January to April 2021 at six health facilities in Dessie Town. A total of 378 community-acquired pneumonia patients suspected to be human immunodeficiency virus-positive were recruited using a consecutive sampling technique. Sociodemographic and clinical data were collected using a structured questionnaire. A two-milliliter sputum specimen was collected aseptically from each study participant. Samples were cultivated on blood agar, chocolate agar and MacConkey agar to isolate bacterial pathogens. To identify bacteria pathogens Gram stain, colony morphology and biochemical tests were performed. The Kirby-Bauer Disc Diffusion method was used to perform the antimicrobial susceptibility test. Descriptive statistics, logistic regression analysis was carried out using Statistical package for social science version 25 software. p-value < 0.05 with a corresponding 95% confidence interval (CI) was considered for statistical significance. Result: The overall prevalence of bacterial pneumonia was 175 (46.3%). Gram-negative bacteria accounted for 119 (68%) and the predominant isolates identified were Streptococcus pneumoniae 49 (28%) followed by Klebsiella pneumoniae 46 (26.3%), Pseudomonas aeruginosa 34 (19.4%). There were 148 (84.6%) multidrug-resistant bacteria overall. Statistically significant factors included viral load, cigarette smoking, cluster of differentiation 4 count, alcohol use, World Health Organization clinical stages III and IV and low white blood cell count. Conclusion: The study found that both multidrug resistance and bacterial pneumonia were high. Thus, bacterial culture and antimicrobial susceptibility tests should be routinely performed in health facilities in order to prevent and control the spread of bacterial infection and concurrent drug resistance.

[1]  Yohannes Zenebe,et al.  Bacterial Profile and Their Antibiotic Resistance Pattern Among HIV Patients Diagnosed with Pneumonia in Felege-Hiwot Referral Hospital, Bahir Dar, Northwest Ethiopia , 2020 .

[2]  S. Mshana,et al.  Prevalence of gram negative bacteria causing community acquired pneumonia among adults in Mwanza City, Tanzania , 2020, Pneumonia.

[3]  M. Getahun,et al.  Bacterial profile and antimicrobial susceptibility patterns of lower respiratory tract infection among patients attending selected health centers of Addis Ababa, Ethiopia , 2020, The Egyptian Journal of Chest Diseases and Tuberculosis.

[4]  Yongjun Wu,et al.  Klebsiella pneumoniae: an increasing threat to public health , 2020, Annals of Clinical Microbiology and Antimicrobials.

[5]  M. Weinstein,et al.  The Clinical and Laboratory Standards Institute Subcommittee on Antimicrobial Susceptibility Testing: Background, Organization, Functions, and Processes , 2020, Journal of Clinical Microbiology.

[6]  A. Morris,et al.  Pathogenesis of HIV-related lung disease: Immunity, infection, and inflammation. , 2020, Physiological reviews.

[7]  E. Deák,et al.  What's New from the CLSI Subcommittee on Antimicrobial Susceptibility Testing M100, 29th Edition , 2019 .

[8]  O. A. Muhie Antibiotic Use and Resistance Pattern in Ethiopia: Systematic Review and Meta-Analysis , 2019, International journal of microbiology.

[9]  F. Biadglegne,et al.  Bacteriology of community acquired pneumonia in adult patients at Felege Hiwot Referral Hospital, Northwest Ethiopia: a cross-sectional study , 2019, Antimicrobial Resistance & Infection Control.

[10]  Yemane Weldu,et al.  Species, Risk Factors, and Antimicrobial Susceptibility Profiles of Bacterial Isolates from HIV-Infected Patients Suspected to Have Pneumonia in Mekelle Zone, Tigray, Northern Ethiopia , 2019, BioMed research international.

[11]  K. Walia,et al.  Establishing Antimicrobial Resistance Surveillance & Research Network in India: Journey so far , 2019, The Indian journal of medical research.

[12]  Feyissa Begna,et al.  ANTIMICROBIAL RESISTANCE: REVIEW , 2018, International Journal of Research -GRANTHAALAYAH.

[13]  Michel Kengne,et al.  Antibiotics susceptibility pattern of Streptococcus pneumoniae isolated from sputum cultures of human immunodeficiency virus infected patients in Yaoundé, Cameroon , 2018, The Pan African medical journal.

[14]  J. Leonardi-Bee,et al.  Alcohol and the risk of pneumonia: a systematic review and meta-analysis , 2018, BMJ Open.

[15]  B. Lubbers,et al.  Applying definitions for multidrug resistance, extensive drug resistance and pandrug resistance to clinically significant livestock and companion animal bacterial pathogens. , 2018, The Journal of antimicrobial chemotherapy.

[16]  Molla Abebe,et al.  Haematological and immunological reference intervals for adult population in the state of Amhara, Ethiopia , 2018, Tropical medicine & international health : TM & IH.

[17]  M. Kibret,et al.  Pharyngeal colonization and drug resistance profiles of Morraxella catarrrhalis, Streptococcus pneumoniae, Staphylococcus aureus, and Haemophilus influenzae among HIV infected children attending ART Clinic of Felegehiwot Referral Hospital, Ethiopia , 2018, PloS one.

[18]  A. Mane,et al.  Aetiological spectrum of severe community-acquired pneumonia in HIV-positive patients from Pune, India , 2018, The Indian journal of medical research.

[19]  I. Enweani,et al.  Microbiological Profile of Respiratory Tract Infections among HIV Sero-positive Subjects Attending Nnamdi Azikiwe University Teaching Hospital Nnewi, Nigeria , 2018 .

[20]  C. Muyodi,et al.  Risk factors for community-acquired pneumonia among adults in Kenya: a case–control study , 2017, Pneumonia.

[21]  Young Bae Kim,et al.  Antimicrobial Resistance of Hypervirulent Klebsiella pneumoniae: Epidemiology, Hypervirulence-Associated Determinants, and Resistance Mechanisms , 2017, Front. Cell. Infect. Microbiol..

[22]  V. Veloso,et al.  Community-acquired lower respiratory tract infections in HIV-infected patients on antiretroviral therapy: predictors in a contemporary cohort study , 2017, Infection.

[23]  V. Kuete,et al.  Bacterial resistance and immunological profiles in HIV-infected and non-infected patients at Mbouda AD LUCEM Hospital in Cameroon. , 2017, Journal of infection and public health.

[24]  Ma Jinghua,et al.  Pathogens and antibiotic resistance of children with community-acquired pneumonia , 2017 .

[25]  J. Molina,et al.  Incidence and risk factor prevalence of community-acquired pneumonia in adults in primary care in Spain (NEUMO-ES-RISK project) , 2016, BMC Infectious Diseases.

[26]  Iain E. Buchan,et al.  Body mass index relates weight to height differently in women and older adults: serial cross-sectional surveys in England (1992–2011) , 2016, Journal of public health.

[27]  G. Kaatz,et al.  Multidrug efflux pumps of Gram-positive bacteria. , 2016, Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy.

[28]  L. Dalar,et al.  Pneumonia in HIV-Infected Patients , 2016 .

[29]  A. d’Arminio Monforte,et al.  Increased risk of virologic failure to the first antiretroviral regimen in HIV-infected migrants compared to natives: data from the ICONA cohort. , 2014, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[30]  Jithendra Kandati,et al.  Bacterial and fungal agents causing lower respiratory tract infections in patients with human immunodeficiency virus infection , 2016 .

[31]  R. Shah Microbiological profile of respiratory tract infections among HIV-infected and HIV-non infected patients : A comparative study , 2016 .

[32]  B. Cao,et al.  Resistance mechanisms. , 2016, Annals of translational medicine.

[33]  C. Whitney,et al.  High Streptococcus pneumoniae colonization prevalence among HIV-infected Kenyan parents in the year before pneumococcal conjugate vaccine introduction , 2015, BMC Infectious Diseases.

[34]  G. Shakya,et al.  Lower respiratory tract infections among HIV positive and control group in Nepal , 2015, VirusDisease.

[35]  A. Cattamanchi,et al.  A Clinical Predictor Score for 30-Day Mortality among HIV-Infected Adults Hospitalized with Pneumonia in Uganda , 2015, PloS one.

[36]  S. Ramirez‐Arcos,et al.  A Comparative Study of McFarland Turbidity Standards and the Densimat Photometer to Determine Bacterial Cell Density , 2015, Current Microbiology.

[37]  R. Bals,et al.  Cigarette smoke-promoted acquisition of bacterial pathogens in the upper respiratory tract leads to enhanced inflammation in mice , 2015, Respiratory Research.

[38]  K. Marwa,et al.  Resistance to Cotrimoxazole and Other Antimicrobials among Isolates from HIV/AIDS and Non-HIV/AIDS Patients at Bugando Medical Centre, Mwanza, Tanzania , 2015, AIDS research and treatment.

[39]  Tsegaye Sewunet,et al.  Antimicrobial susceptibility pattern of bacterial isolates from community-acquired pneumonia patients in Jimma University Specialized Hospital, Jimma, Ethiopia , 2015 .

[40]  Yadav Khushbu,et al.  Bacteriological Profile of Lower Respiratory Tract Infection (LRTI) among HIV Seropositive Cases in Central Terai of Nepal , 2015 .

[41]  Subir Kundu,et al.  The Battle Against Microbial Pathogens : Basic Science , Technological Advances and Educational Programs , 2015 .

[42]  A. Liwa Antimicrobial resistance: Mechanisms of action of antimicrobial agents , 2015 .

[43]  Belayneh Regasa Drug Resistance Patterns of Bacterial Pathogens from Adult Patients with Pneumonia in Arba Minch Hospital, South Ethiopia , 2014 .

[44]  Thomas Ferkol,et al.  The global burden of respiratory disease. , 2014, Annals of the American Thoracic Society.

[45]  J. Miro,et al.  Community-acquired lung respiratory infections in HIV-infected patients: microbial aetiology and outcome , 2014, European Respiratory Journal.

[46]  O. OjoBola.,et al.  Antibiotics Resistance of Bacteria Associated with Pneumonia in HIV/AIDS Patients in Nigeria , 2014 .

[47]  K. Anuradha,et al.  Drug Susceptibility Pattern of Aerobic Bacterial isolates from Pulmonary Infection in HIV Seropositives and their Correlation with CD4 Count , 2014 .

[48]  U. Menon,et al.  Etiology and Anti-microbial Sensitivity of Organisms Causing Community Acquired Pneumonia: A Single Hospital Study , 2013, Journal of family medicine and primary care.

[49]  Ronald Anderson,et al.  HIV-associated bacterial pneumonia. , 2013, Clinics in chest medicine.

[50]  H. Nepal,et al.  Lower respiratory tract pathogens and their antimicrobial susceptibility pattern in a medical hospital of central Nepal , 2013 .

[51]  A. Morris,et al.  Pathogenesis of HIV and the Lung , 2013, Current HIV/AIDS Reports.

[52]  M. Falagas,et al.  Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance. , 2012, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[53]  A. Torres,et al.  Pulmonary infections in HIV-infected patients: an update in the 21st century , 2011, European Respiratory Journal.

[54]  M. Molyneux,et al.  Etiology of suspected pneumonia in adults admitted to a high-dependency unit in Blantyre, Malawi. , 2011, The American journal of tropical medicine and hygiene.

[55]  I. Marinou,et al.  Cepheid GeneXpert MTB/RIF Assay for Mycobacterium tuberculosis Detection and Rifampin Resistance Identification in Patients with Substantial Clinical Indications of Tuberculosis and Smear-Negative Microscopy Results , 2011, Journal of Clinical Microbiology.

[56]  E. Bateman,et al.  HIV-1 and bacterial pneumonia in the era of antiretroviral therapy. , 2011, Proceedings of the American Thoracic Society.

[57]  A. Morris,et al.  An official ATS workshop report: Emerging issues and current controversies in HIV-associated pulmonary diseases. , 2011, Proceedings of the American Thoracic Society.

[58]  A. Hidrón,et al.  Methicillin-resistant Staphylococcus aureus in HIV-infected patients , 2010, Infection and drug resistance.

[59]  P. Easterbrook,et al.  Pneumonia in HIV-infected persons: increased risk with cigarette smoking and treatment interruption. , 2008, American journal of respiratory and critical care medicine.

[60]  A. Ferrer,et al.  Bacterial pneumonia in HIV‐infected patients: use of the pneumonia severity index and impact of current management on incidence, aetiology and outcome , 2008, HIV medicine.

[61]  M. Carey,et al.  Tobacco smoking among low-income Black women: demographic and psychosocial correlates in a community sample. , 2008, Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco.

[62]  A. O'donnell,et al.  Pulmonary infections in the HIV-infected patient in the era of highly active antiretroviral therapy: An update , 2007, Current infectious disease reports.

[63]  A. Salami,et al.  Bacterial pneumonia in the AIDS patients. , 2007, West African journal of medicine.

[64]  H. McShane Co-infection with HIV and TB: double trouble , 2005, International journal of STD & AIDS.

[65]  P. Ringwald,et al.  Antimicrobial resistance. , 2001, Emerging infectious diseases.